Capacity scale-ups to drive Epigral's ₹5,000 crore target by FY31: CMD Maulik Patel

The company expects to reach ₹2,900 crore in revenue this fiscal year following revenue of ₹2,500–2,530 crore in 2026
Key takeaways
- Category: Company.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.














